Semax vs Hexarelin
A comprehensive, data-driven comparison of Semax and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Semax | Hexarelin Examorelin |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Cognitive Enhancement | Growth Hormone |
| Primary Use | Cognitive enhancement and neuroprotection | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $45 - $90/mo | $40 - $80/mo |
| Administration | Nasal spray | Subcutaneous injection |
| Typical Dose | 2-3 drops per nostril 2-3x daily | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | Daily | Daily |
| Mechanism | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Hexarelin is generally more affordable ($40 - $80/mo) compared to Semax ($45 - $90/mo).
- 2Semax is administered via nasal spray, while Hexarelin uses subcutaneous injection.
- 3Semax has moderate-quality evidence, while Hexarelin has emerging-quality evidence.
- 4They belong to different categories: Semax (Cognitive Enhancement) vs Hexarelin (Growth Hormone).
Which Is Better For...
Hexarelin
More budget-friendly option with lower monthly costs
Semax
Fewer commonly reported side effects
Semax
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Semax | $45 - $90/mo | Not submitted | Various research labs |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
Semax typically costs $45 - $90/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Semax is not FDA-approved (Not submitted). Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Semax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Semax and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.